- Dr. Anthony Fauci said Monday that the Johnson and Johnson vaccine pause should not last long.
- "It's gonna be more like days to weeks rather than weeks to months," Fauci said of the delay.
- The Johnson and Johnson vaccine rollout was paused in both the US and South Africa on Tuesday over extremely rare blood clot reports.
- For more articles, go to www.BusinessInsider.co.za.
Dr. Anthony Fauci, chief medical advisor to US President Joe Biden, said on Tuesday that according to his understanding of guidance from the US health authorities, the Johnson and Johnson vaccine pause should only last "days to weeks."
"What I heard from the previous press discussion was it's gonna be more like days to weeks rather than weeks to months," Fauci said when asked about the extent of the delay at a White House press briefing.
Dr. Janet Woodcock, the acting commissioner of the US Food and Drug Administration (FDA), told reporters earlier in the day that she expects the halt to be temporary.
"We expect it to be a matter of days for this pause," Woodcock said.
The Johnson and Johnson vaccine rollout was paused in both the US and South Africa on Tuesday over extremely rare blood clot reports.
Johnson and Johnson also announced it would delay the rollout of its Covid-19 vaccine in Europe hours after US health officials called for authorities to pause using the vaccine.
Officials with the US Centers for Disease Control and Prevention said Tuesday that health agencies should immediately pause giving the shot, citing an "abundance of caution" over extremely rare reports of blood clotting among the millions of doses administered.
Six women who had received the vaccine had developed the clots - out of the seven million Americans who have received the Johnson & Johnson jab. All six recipients were women between the ages of 18 and 48, according to The New York Times. One of the women died.
That there have been no cases of blood clots among the almost 300,000 health-workers already vaccinated with the Johnson & Johnson jab in South Africa.
South Africa has ordered more than 30 million of these vaccines, which are filled at an Aspen plant in Gqeberha in the Eastern Cape.